THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,308 | -19.1% | 46,965 | -3.0% | 0.00% | 0.0% |
| Q2 2023 | $500,940 | -9.1% | 48,400 | -4.7% | 0.00% | -50.0% |
| Q1 2023 | $550,996 | -14.5% | 50,783 | -11.6% | 0.00% | 0.0% |
| Q4 2022 | $644,589 | +12.5% | 57,450 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $573,000 | +6.7% | 56,550 | -4.5% | 0.00% | +100.0% |
| Q2 2022 | $537,000 | -14.4% | 59,232 | -9.7% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -13.5% | 65,600 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $725,000 | +49.5% | 65,600 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $485,000 | -49.1% | 65,600 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $953,000 | -28.8% | 65,600 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,339,000 | +14.8% | 65,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,166,000 | +6.9% | 65,600 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $1,091,000 | -29.6% | 73,800 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $1,549,000 | -11.6% | 73,800 | -2.6% | 0.00% | -33.3% |
| Q1 2020 | $1,752,000 | +2.0% | 75,800 | +14.3% | 0.01% | +50.0% |
| Q4 2019 | $1,717,000 | +32.9% | 66,300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,292,000 | +26.4% | 66,300 | +5.9% | 0.00% | +33.3% |
| Q2 2019 | $1,022,000 | -21.2% | 62,600 | +9.4% | 0.00% | -25.0% |
| Q1 2019 | $1,297,000 | +14.9% | 57,200 | +29.7% | 0.00% | 0.0% |
| Q4 2018 | $1,129,000 | -20.7% | 44,100 | +1.1% | 0.00% | 0.0% |
| Q3 2018 | $1,424,000 | +44.0% | 43,600 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $989,000 | +31.5% | 43,600 | +40.6% | 0.00% | +50.0% |
| Q1 2018 | $752,000 | -13.1% | 31,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $865,000 | -18.5% | 31,000 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $1,061,000 | -14.1% | 31,000 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $1,235,000 | -37.8% | 31,000 | -64.0% | 0.00% | -42.9% |
| Q3 2014 | $1,987,000 | -27.7% | 86,200 | 0.0% | 0.01% | -30.0% |
| Q2 2014 | $2,748,000 | – | 86,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |